FAST NEWS: CanSino’s revenue plunges as demand dries up for Covid vaccines
The latest: CanSino Biologics Inc. (6185.HK; 688185.SH) announced on Wednesday it recorded a net loss of 1.28 billion yuan ($176 million) in the first half of this year, reversing a 16.04…
Weak Markets Overshadow Sunshine Insurance IPO Plan
The mid-sized Chinese insurer has filed a second time to list in Hong Kong, though reports that it aims to raise up to $1 billion look exaggeratedKey Takeaways:Sunshine Insurance could…
FAST NEWS: WuXi AppTec Posts 73% Increase in Earnings, Benefiting from Higher Revenue
The latest: Pharmaceutical services outsourcing company WuXi AppTec Co. Ltd. (2359.HK; 603259.SH) announced Friday its net profit for the first half of 2022 was approximately 4.64 billion yuan ($690 million), representing a year-over-year…
FAST NEWS: Xinjiang Goldwind Posts Strong Profit Growth, But Revenue Decline, in First Quarter
The latest: Wind power equipment maker Xinjiang Goldwind Science & Technology Co. Ltd. (2208.HK; 002202.SZ) said late Tuesday its revenue fell 8.3% in the first quarter of 2022 to 6.4…
Recent Articles
RELATED ARTICLES
-
Dispute over Covid vaccines casts doubt on Clover Bio recovery
2197.HK -
Zhengye Biotech’s ‘pet-sized’ IPO leaves plenty of room for more fundraising
ZYBT.US
-
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK
-
WuXi Biologics sells vaccine plant as new U.S. law looms
2269.HK
-
Yan Palace flies back to profit growth as revenue sags
1497.HK
